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Background: Vigabatrin (VGB) is an anti-epileptic medication which has been linked to peripheral constriction of
the visual field. Documenting the natural history associated with continued VGB exposure is important when making
decisions about the risk and benefits associated with the treatment. Due to its speed the Swedish Interactive
Threshold Algorithm (SITA) has become the algorithm of choice when carrying out Full Threshold automated static
perimetry. SITA uses prior distributions of normal and glaucomatous visual field behaviour to estimate threshold
sensitivity. As the abnormal model is based on glaucomatous behaviour this algorithm has not been validated for VGB
recipients. We aim to assess the clinical utility of the SITA algorithm for accurately mapping VGB attributed field loss.
Methods: The sample comprised one randomly selected eye of 16 patients diagnosed with epilepsy, exposed to VGB
therapy. A clinical diagnosis of VGB attributed visual field loss was documented in 44% of the group. The mean age
was 39.3 years ± 14.5 years and the mean deviation was -4.76 dB ±4.34 dB. Each patient was examined with the Full
Threshold, SITA Standard and SITA Fast algorithm.
Results: SITA Standard was on average approximately twice as fast (7.6 minutes) and SITA Fast approximately 3 times
as fast (4.7 minutes) as examinations completed using the Full Threshold algorithm (15.8 minutes). In the clinical
environment, the visual field outcome with both SITA algorithms was equivalent to visual field examination using the
Full Threshold algorithm in terms of visual inspection of the grey scale plots , defect area and defect severity.
Conclusions: Our research shows that both SITA algorithms are able to accurately map visual field loss attributed to
VGB. As patients diagnosed with epilepsy are often vulnerable to fatigue, the time saving offered by SITA Fast means
that this algorithm has a significant advantage for use with VGB recipients.
Keywords: Swedish interactive threshold algorithm, Vigabatrin, Visual fieldBackground
Vigabatrin (VGB) is the first purposely designed anti-
epileptic medication. It is administered as a first line
therapy to patients suffering from Infantile Spasms and
as an adjunctive therapy to patients with complex partial
seizures [1,2]. VGB was initially approved for use within
the United Kingdom and several other European countries
in 1989 however, it is now well established that VGB ther-
apy can induce peripheral constriction of the visual field.
Reports of the prevalence of this defect range between
17% [3] and 86% [4]. The risk of VGB attributed field loss* Correspondence: miriam.conway.1@city.ac.uk
1Department of Optometry and Visual Science, City University London,
Northampton Square, London EC1V OHB, UK
Full list of author information is available at the end of the article
© 2014 Conway et al.; licensee BioMed Centra
Commons Attribution License (http://creativec
reproduction in any medium, provided the or
Dedication waiver (http://creativecommons.or
unless otherwise stated.appears to be lower in children less than 12 years old ex-
posed to VGB [5] when compared to adults and adolescents
who receive VGB at a later age [6]. General consensus
suggests that the visual field loss is permanent [7,8]. Posi-
tive relationships between the visual field loss and cumula-
tive dosage [3,8-10] duration of vigabatrin therapy [6,8-11]
and maximum daily dosage [12] have all been documented.
Despite these known side effects, in the last few years VGB
has become licensed in Canada, Mexico and the United
States for the same uses as reported above.
Patients receiving VGB are frequently monitored using
either kinetic perimetry or automated static perimetry
[13]. Vigabatrin attributed visual field loss is two and a
half times more common with automated static perimetryl. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Table 1 The test order sequence randomly assigned to
patients
Protocol Test order sequence for
visit 2 and visit 3
First Session Rest period Second Session
A Full Threshold 30 minute
rest period
SITA Standard then
SITA Fast
B Full Threshold 30 minute
rest period
SITA Fast then
SITA Standard
C SITA Standard then
SITA Fast
30 minute
rest period
Full Threshold
D SITA Fast then
SITA Standard
30 minute
rest period
Full Threshold
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authors attributed these findings to the fact that in gen-
eral, static perimetry is more sensitive than kinetic perim-
etry for the detection of field loss [15]. Static perimetry
is normally carried out using the Swedish Interactive
Threshold Algorithms (SITA). These algorithms were
developed with the specific aim of offering a significant
reduction in examination time but without sacrificing
any loss in the accuracy of threshold estimation when
compared to the Full Threshold and FASTPAC algorithms
[16,17].
SITA is based on prior distributions of normal and ab-
normal visual field behaviour to estimate the threshold.
The prior distribution models contain information on age-
corrected normal threshold values, frequency-of-seeing
curves, between-subject variability and inter-point correla-
tions between thresholds [16]. The abnormal visual field
model is based on a glaucomatous population and thus
inter-point correlations of threshold values would be
based upon the retinal nerve fibre arrangement [18].
VGB induced visual field loss however is thought to result
from a toxic effect in the retina and as such may not pre-
cisely conform to the nerve fibre bundle. Consequently,
SITA may map a response for VGB recipients which are
artificially influenced by the glaucomatous model.
To date, the only study to have examined whether SITA
was valid in patients with non-glaucomatous pathologies,
such as optic neuropathies and hemianopias, reported that
SITA Standard was at least as good as Full Threshold for
the detection of visual loss in individual examinations
[19]. For VGB recipients it is essential that we accurately
document the natural progression associated with contin-
ued VGB exposure. This information is vital when making
decisions on management as it allows the patient and
practitioner an opportunity to weigh up the risks and
benefits associated with continued treatment.
The aim of this investigation was to assess the clinical
utility of the SITA algorithms for the investigation of pa-
tients receiving VGB. Firstly, by determining the threshold
agreement between the different algorithms. Secondly, by
determining the threshold agreement within the same al-
gorithm across two successive visits. Thirdly, the agree-
ment of the diagnostic outcome was assessed in terms of
area and depth of defect.
Methods
Twenty-Two participants: 12 females and 10 males
(mean age 38.54 years, SD 13.45, range 16 to 61 years)
who were undergoing or who had previously undergone
treatment with VGB were invited to take part in the study.
Four participants were removed from the study as they
had a visual field defect not attributed to VGB another
two participants were removed because of poor reliability.
The sample therefore consisted of 16 epilepsy patients; 10females and 6 males (mean age 39.3, SD 14.52, range 18 to
61). Patients were recruited from National Health Service
hospitals in the United Kingdom and written informed
consent was obtained from each participant prior to com-
mencement of the study. Approval for the study was given
by the Aston University Human Sciences Ethical Com-
mittee and adhered to the tenets of the Declaration of
Helsinki.
Vigabatrin recipients had their visual field measured
using both SITA strategies and the Full Threshold algo-
rithm. The Full Threshold algorithm does not use prior
distributions of normal and abnormal visual field behav-
iour to estimate threshold sensitivity but instead employs
a 4-2 dB staircase to estimate each threshold sensitivity.
The design of the Full Threshold algorithm ensures that
the visual field is not artificially influenced by prior models
and therefore provided the gold standard for mapping
VGB attributed field loss. At the first visit, all patients
underwent a 30-2 visual field examination on both eyes
using the Full Threshold algorithm (Humphrey Field
Analyser 750 software version A10.2). This visit served
to reduce the learning effect observed in perimetry [20]
and the results were not used for data analysis. At the
second and third visits, each patient underwent perimetry
on one randomly assigned eye which remained constant
for a given patient according to one of four randomly
assigned protocols (Table 1). This unconventional order
protocol was designed to induce similar degrees of fatigue
within all three algorithms by ensuring that the first and
second test sessions were of similar duration.
Visual fields obtained from the left eye were changed
to the right eye format and the stimulus locations imme-
diately above and below the blind spot were removed
from the analysis which was twofold. Firstly, threshold data
was evaluated in terms of threshold agreement between al-
gorithms (during visit 3) and threshold agreement within
algorithm (between visit 2 and 3). The second analysis was
in terms of the clinical status of the visual field both within
and between threshold algorithms.
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The sample comprised a typical cross section of VGB
therapy patients (Table 2). Forty four percent of the pa-
tients had a confirmed clinical diagnosis of VGB attrib-
uted field loss from their medical records. The diagnosis
was made independently from the research study for
purely clinical purposes. Visual field defects exhibited
a bilateral symmetrical defect showing concentric con-
striction of the peripheral visual field which was more
pronounced nasally and typically characteristic of VGB
attributed field loss. The other 66% of the sample had
a confirmed clinical diagnosis of no visual field loss
from their medical records. All patients had a visual acuity
of 6/9 or better and ametropia not exceeding ±5.00 day
and ±2.50 day of astigmatism. No patient had a history of
ocular disease or previous surgery to their eye or brain. All
visual fields fell inside the criteria of less than 33% false
positive, less than or equal to 33% false negative and
20% fixation losses (see Additional file 1: Table S1). We
acknowledge that the false negative rate was higher for
the patients with significant visual field loss. However,
it is now well recognised in perimetry that the false nega-
tive catch trial methods are not suitable for estimating pa-
tient attentiveness in eyes with significant visual field
loss visual field loss as the frequency of false-negative
responses in eyes with visual field defects is associated
with amount of field loss [21].Table 2 The seizure history of the patient group and the epil
Patient
number
Seizure
history
Carbamazepine Sodium
valporate
Clobazam Levet
1 Unknown
2 generalised X X X
3 Complex partial
partial/secondary
generalised
4 Complex partial
5 Simple/complex X
6 Complex partial X
7 Complex partial X
8 Unknown X
9 Generalised
10 Complex partial X
11 Complex partial X
12 Unknown X
13 Generalised X X
14 Complex partial
partial/secondary
generalised
15 Unknown X X
16 Complex partial
partial/secondary
generalised
XThreshold agreement between and within algorithms
One-way analysis of variance (between-subject) was used
to determine whether there was any significant difference
between examination duration, mean sensitivity (MS) mean
deviation (MD) and pattern standard deviation (PSD), in
any of the three algorithms resulting from the various
sequence options of perimetric examination. There was no
significant difference between protocol and visual field
index at the third visit indicating that the unconventional
order protocol did not influence threshold sensitivities.
The group mean values for MS, MD, PSD and test dur-
ation (±1 SD) for each algorithm at the second and third
visits are illustrated in Table 3.
For MD and PSD, there was no difference between algo-
rithms or visit order. The mean sensitivity of SITA Stand-
ard was 1.25 dB higher and 1.51 dB higher for the SITA
Fast algorithm at the final visit compared to the Full
Threshold algorithm SITA Standard (7 .6 minutes) and
SITA Fast (4.7 minutes) were significantly faster than
Full Threshold perimetry (15.8 minutes).
The threshold agreement within each algorithm across
2 successive visits was assessed by calculating the root
mean square error (RMSE) for all test locations, partici-
pants and algorithms. The visual field was sectorised into
outer, middle and inner zones of eccentricity; the outer
zone comprised of 24 points from 25.8 to 28.5 degrees from
fixation, the middle zone comprised 20 stimulus locationseptic medications concomitant with vigabatrin
iracetam Topiramate Lamotrogine Phenytoin Gabapentin Other
X X
X X X
X X
X
X
X
X
X
X
X
X X X
X
X
X X
Conway et al. BMC Ophthalmology 2014, 14:166 Page 4 of 10
http://www.biomedcentral.com/1471-2415/14/166from 21.2 to 22.8 degrees from fixation and the inner zone
comprised of 30 stimulus locations from 4.2 to 17.5 degrees
from fixation (Figure 1). Figure 2 shows the 95% confidence
intervals for the RMSE as a function of threshold algorithm
for the whole field and the outer, middle and inner visual
field regions. Within algorithm threshold variability was
lowest in the inner ring for all threshold algorithms. As sec-
tors increase in eccentricity from fixation, the group mean
RMSE increased indicating less threshold agreement within
an algorithm across visits 2 and 3. Both SITA algorithms
had less threshold agreement (group mean RMSE) and lar-
ger confidence intervals across all visual field regions when
compared to Full Threshold (Figure 2). Within the outer
field region the RMSE with SITA Fast was 27% higher than
Full Threshold and SITA Standard was 19% higher than
Full Threshold (p = 0.017). Similar differences were found
across all field regions.
Clinical status of the visual field
All visual fields were categorised using the classification
defined by Wild et al. (2009) [22]. Visual defects ranged
from mild to severe (Table 4) based on the number and
position of stimulus locations exhibiting an abnormality
at either p < 0.01 or p < 0.005 out to 30 degrees eccentri-
city for static threshold perimetry and were present in
38% after Full threshold was assigned the gold standard
for the detection of VGB attributed visual field loss. The
false positive and false negative rate was then calculated
for both SITA algorithms. False positive rate was defined
as the proportion of persons falsely identified as diseased
persons by SITA Standard or SITA Fast in those without
any VGB attributed field loss identified by the gold stand-
ard Full Threshold algorithm. One patient was falsely di-
agnosed as having VGB attributed visual field loss with
both SITA algorithms when there was none documented
on Full Threshold (1/10 = 10%) suggesting that the false
positive rate was 10% for both SITA algorithms. Closer in-
spection of the “normal” Full Threshold visual field plot
(patient 15 Figure 3) reveals that if those locations demon-
strating a 2% loss on pattern probability analysis were also
included in the analysis then the patient would have beenTable 3 Group global indices and examination times
Fu
Mean sensitivity (dB) Visit 2
Visit 3
Mean deviation (dB) Visit 2
Visit 3
Pattern standard deviation (dB) Visit 2
Visit 3
Examination time (seconds) Visit 2 9
Visit 3 9diagnosed with a VGB attributed defect. Additionally,
information from their medical records shows that this
patient had a confirmed clinical diagnosis of VGB at-
tributed field loss from previous visual field testing.
The false negative rate was defined as the proportion of
persons falsely identified as normal by SITA Standard
or SITA Fast, among people with VGB attributed field
loss identified by the gold standard Full Threshold algo-
rithm. SITA standard correctly identified all patients with
VGB attributed field loss documented on Full Threshold
as having VGB attributed field loss on SITA standard sug-
gesting a false negative rate of 0%. One patient was falsely
identified as being normal with SITA Fast when there was
a VGB attributed defect on the Full Threshold algorithm
(1/6) suggesting a false negative rate of 17%. Closer in-
spection of the falsely identified field (patient 7 Figure 3)
reveals that if those locations demonstrating a 2% loss on
shape probability analysis were also included in the analysis
then the patient would have been correctly diagnosed.
To further assess the similarity in area of any visual field
defect mapped by each threshold algorithm the number of
non-overlapping defects or normal locations between two
visual fields i.e. the dissimilarity between the fields was cal-
culated and expressed as a percentage of the total number
of visual field locations. Comparisons were made between
threshold algorithms at visit 3 and also within each algo-
rithm between visits 2 and 3. The group mean differences
are illustrated in Table 5.
For total deviation probabilities, the average area of vis-
ual field defect between two threshold algorithms at the
final visit varied by up to 17%. Although the least variation
was demonstrated between Full Threshold and SITA
Standard none of the differences were found to be sta-
tistically significant. Using a given threshold algorithm
the average area of visual field defect varied by a max-
imum of 20% of stimulus locations between the second
and third visits. Although SITA Fast yielded the great-
est difference there was no statistical difference in this
variability between threshold algorithms.
In order to demonstrate how each SITA algorithm dis-
plays the spatial pattern of VGB attributed field loss. Thell threshold SITA standard SITA fast
24.30 (5.28) 25.30 (5.66) 26.14 (5.36)
24.05 (5.04) 25.30 (6.29) 25.56 (5.34)
−4.24 (4.00) −4.25 (4.46) −3.90 (4.76)
−4.89 (3.79) −5.06 (4.98) −4.34 (4.25)
4.70 (3.67) 4.78 (3.91) 3.99 (3.30)
4.89 (3.51) 4.95 (3.97) 4.63 (3.64)
37.0 (157.9) 449.0 (80.9) 279.4 (79.2)
56.6 (165.1) 464.1 (99.4) 282.3 (67.3)
Figure 1 Illustration of outer (black), middle (grey) and inner
(white) sectors (blind spot dashed lines).
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for every patient with confirmed VGB attributed field
loss (Figure 3) and also those without visual field loss
(Additional file 2: Figure S1). Visual field plots were gener-
ated from the Humphrey sensitivity values (dB) using soft-
ware which is freely available from one of the authors (HZ)
[23,24]. Visual inspection of the plots shows they were
approximately equivalent, for all 3 algorithms, for every
patient with and without a confirmed VGB attributed
visual field defect.Figure 2 Root Mean Square Error (dB) and 95% Confidence Intervals
ring and inner ring.In order to analyse differences between algorithms in
estimating defect depth, each stimulus location was given
a numerical value corresponding to the level of total or
pattern deviation significance (0 = not significant, 1 = 5%,
2 = 2%, 3 = 1%, 4 = 0.5%). For every patient the sum of all
visual field locations was calculated for each algorithm
for both total and pattern deviation probability plots
(Figure 4). A repeated measures analysis of variance was
conducted to explore any differences in estimating defect
depth across all three algorithms for either total or pattern
deviation probability plots. As you can see from Figure 4
overall the SITA Standard algorithm produced the most
severe visual field loss, for each patient followed by SITA
Fast and Full Threshold. These small differences however
did not reach statistical significance between algorithms
for either total deviation or the pattern deviation probabil-
ity plots.
Discussion
The findings that both SITA Standard was on average
approximately twice as fast (7.6 minutes) and SITA Fast
approximately 3 times as fast (4.7 minutes) as examina-
tions completed using the Full Threshold algorithm
(15.8 minutes) is in agreement with other studies of SITA
in the normal population [25,26] in the investigation of
glaucoma [27] and neuro-ophthalmological conditions [19]
and adds nothing new to the existing literature. Test dur-
ation is of particular importance when examining patients
with epilepsy as they are more prone to fatigue than other
patient groups [28]. Researchers have shown that approxi-
mately 25% of patients (n = 734) with epilepsy are unable
to produce a conclusive visual field test at any visit [14].
This finding suggests that examination speed is particularlyas a function of algorithm for the whole field, outer ring, middle
Table 4 Severity classification for all patients categorised
using criteria by Wild et al. (2009) [19]
Patient no. Full threshold SITA standard SITA fast
Classification Classification Classification
1 Severe Severe Severe
2 Moderate Moderate Moderate
3 Nil Nil Nil
4 Nil Nil Nil
5 Moderate Moderate Moderate
6 Nil Nil Nil
7 Mild Mild Nil
8 Nil Nil Nil
9 Nil Nil Nil
10 Nil Nil Nil
11 Severe Severe Severe
12 Nil Nil Nil
13 Nil Nil Nil
14 Severe Severe Severe
15 Nil Severe Moderate
16 Nil Nil Nil
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to suggest that ocular imaging of the retinal nerve fibre
layer [29,30] might be a useful technique for those patients
who are unable to carry out perimetry. Based on examin-
ation times our results suggest that SITA Fast would be the
obvious choice of algorithm however it is vital that the
algorithm of choice is able to yield both a high threshold
agreement and a comparable diagnostic outcome equiva-
lent to the Full Threshold algorithm.
Compared to the Full Threshold algorithm, the group
mean pointwise sensitivities were on average 1.1 dB greater
for SITA Standard and 1.7 dB greater for SITA Fast
(Table 3). These results are concordant with findings
in both normal and glaucomatous populations which
report higher sensitivity as a function of algorithm in
the order Full Threshold < SITA Standard < SITA Fast
[31]. The higher sensitivity of SITA compared to the
Full Threshold algorithm would be expected in SITA
as the threshold is defined as the stimulus intensity
which has a probability of seeing of 50% whereas in
Full Threshold the estimate is the last seen stimulus
using a step size of 2 dB [32]. Differences between SITA
types could be explained by the greater imprecision in
threshold estimate of SITA Fast which is integral to the
design of the algorithm [16].
When considering the global indices MD and PSD there
was no significant difference between any of the algorithms
which suggests that they are interchangeable as diagnostic
algorithms. However, global measures of the visual field
status do not give a true representation of the nature and
depth of visual field loss and do not yield any spatial infor-
mation relating to the extent of visual field loss. Thus, it is
necessary to examine the pointwise differences in sensitiv-
ity between and within threshold algorithms.
Threshold agreement within and between algorithms
when defined by the RMSE was assessed for the whole
visual field and in the concentric outer, middle and inner
rings (Figure 1). Each algorithm yielded the smallest group
RMSE within the inner rings and the greatest RMSE for
the outer ring. This finding is unsurprising as the inner
visual field ring is relatively spared by VGB toxicity and
predominantly yields thresholds which are considered
within the normal range. Furthermore, normal threshold
variability increases with eccentricity which is reflected in
greater confidence intervals in the visual field periphery
[18]. As the frequency of defect in VGB toxicity is greatest
in the outer ring [12], the magnitude of the RMSE is also
greater because this visual field area is damaged and thus
contains a wider range of threshold values. Both SITA
algorithms had less threshold agreement (group mean
RMSE) and larger confidence intervals across all visual field
regions when compared against Full Threshold (Figure 2).
Within the outer field region the RMSE with SITA Fast
was 27% higher than Full Threshold and SITA Standardwas 19% higher than Full Threshold. Similar differences
were found across all field regions suggesting that the
SITA algorithms are equivalent methods for quantifying
VGB attributed field loss. Visual fields are often unreli-
able in patients diagnosed with epilepsy [6]. When evaluat-
ing serial visual field tests researchers have reported that
VGB recipients often show a variable degree of “normal”
fluctuation that is not related to the pathological damage
itself [33]. Both SITA algorithms demonstrated slightly
less threshold agreement and larger between-subject vari-
ability when compared against the Full threshold algorithm
(Figure 2). This might be because the faster paced SITA
algorithms might be slightly more difficult in patients
diagnosed with epilepsy either because of the aetiology
associated with the epilepsy itself or because of the
combination of medications that they are receiving.
Diagnostic outcome agreement was assessed in terms
of false positive and false negative rate, area of defect,
grey scale plots and depth of the defect. Results have in-
dicated that the false negative rate was 0% for SITA
Standard and 17% for SITA Fast. Closer inspection of the
one falsely identified field reveals that if those locations
which demonstrated a 2% loss on shape probability ana-
lysis were also included in the analysis then the patient
would also have been correctly diagnosed as having VGB
attributed field loss using SITA Fast. The false positive
rate of both SITA strategies was 10% (n = 1). Further in-
spection of the “normal” visual field documented with
Full Threshold algorithm however suggests a borderline
visual field defect suggestive of VGB toxicity. Additionally,
Patient 1 
Patient 7  
Patient 5  
Patient 2  
Patient 11  
Patient 14  
Patient 15  
Figure 3 Grey Scale plots for all patients with a VGB attributed visual field defect: left Full Threshold, middle SITA Standard, right SITA Fast.
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Figure 4 Showing the sum of total deviation aggregate (Top)
and pattern deviation aggregate (bottom) probability levels for
every patient.
Table 5 Group mean percentage of dissimilar total probability stimulus locations classified as normal or defective
(±1 SD) between threshold algorithms at the final visit (top) and between examinations using the same threshold
algorithm (bottom)
Percentage difference in defect area between threshold algorithm
(at Visit 3)
Full Threshold - SITA Standard Full Threshold - SITA Fast SITA Standard - SITA Fast
Total deviation 16.2 (16.8) 17.1 (17.9) 17.1 (17.5)
Percentage difference in defect area within threshold algorithm
(between Visits 2 and 3)
Full Threshold SITA Standard SITA Fast
Total deviation 14.0 (14.2) 13.0 (13.3) 19.6 (20.5)
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a clinical diagnosis of a VGB attributed field loss on previ-
ous visual field testing. This finding suggests that both
SITA were correct in their diagnosis of a VGB attributed
defect and the false positive rate was therefore 0%.
On average, in terms of defect area there was a lack of
coincidence of the defect at approximately 17% of stimulus
locations (total deviation probability). This inconsistency
may reflect the normal physiological and psychological
factors which influence perimetric examination [20,34].
When one threshold algorithm was compared to another,
the level of probability defining the defect depth showed
little difference across all algorithms. Whilst SITA Stand-
ard gave comparable results to the Full Threshold al-
gorithm in terms of the defect depth at successive
examinations, SITA Fast showed slightly less agree-
ment. However, this difference was small and there
was no statistical difference in this variability between
threshold algorithms consequently this factor is not
expected to confound clinical diagnosis. Results are in
agreement with a visual inspection of the grey scale plots
which reveals that all 3 algorithms produce equivalent
field loss in relation to their grey scale plots (Figure 3).
Overall SITA Standard algorithm appeared to show
the greatest severity of visual field loss, for each patient
followed by SITA Fast and Full Threshold (Figure 4).
These small differences however again did not reach stat-
istical significance between algorithms for either total de-
viation or the pattern deviation probability plots.
Our research was able to detect differences between al-
gorithms on both a global and regional level suggesting
that the sample size was large enough to detect these sub-
tle differences. However like most studies we acknowledge
that our study would probably benefit from replication.
We have demonstrated that the SITA threshold modelling
procedure is capable of mapping the nature of VGB in-
duced visual field loss in terms of its area and depth. In
the ideal clinical environment the optimal threshold algo-
rithm used in perimetry should be fast but able to accur-
ately estimate the threshold consistently across successiveexaminations. Until the arrival of SITA there was always a
trade off between reducing speed of examination and
increasing variability in the threshold which had implica-
tions for both initial diagnosis and monitoring of visual
field loss over time.
In the clinical environment, the visual field outcome with
both SITA algorithms was directly equivalent to visual field
examination using the Full Threshold algorithm in terms
of defect area, defect severity and visual inspection of the
grey scale plot. SITA was not comparable when threshold
agreement within each algorithm (RMSE) was calculated
between Full Threshold and the SITA algorithms for the
outer ring (p = 0.017). When we analyzed how these small
differences in threshold agreement transferred into the
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between two visual fields within the same algorithm. We
found little variation suggesting that these differences have
little clinical impact.
The only other study to have evaluated SITA’s efficacy
in detecting eye disease other than glaucoma concluded
that SITA Standard was at least as good as the Full Thresh-
old in detecting both optic neuropathy and hemianopic
visual field loss [19]. The authors were unable to comment
on SITA’s efficacy in examining these pathologies across
visits as they did not carry out serial visual field tests.
Conclusion
Our research shows that both SITA algorithms are able
to accurately map visual loss attributed to VGB across 2
successive examinations. Our findings in conjunction with
the knowledge that patients diagnosed with epilepsy are
particularly vulnerable to fatigue [28] suggest that SITA
Fast might have an advantage when testing this particular
group of patients.
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visual field defect: left Full Threshold, middle SITA Standard, right SITA Fast.
Competing interests
Miriam Conway had her PhD funded by Aventis Pharmaceuticals.
Authors’ contributions
MLC participated in the study design, data acquisition, statistical analysis,
write up. SH participated in the write up. HZ participated in the statistical
analysis & write up. RC participated in the statistical analysis & write up.
Acknowledgments
We would like to thank Professor John Wild for his help with the study.
Author details
1Department of Optometry and Visual Science, City University London,
Northampton Square, London EC1V OHB, UK. 2Department of Optometry
University of Melbourne, University of Melbourne, 32 Gisborne Street, East
Melbourne, VIC 3002, Australia. 3Optometry & Vision Sciences, School of Life
& Health Sciences, Aston University, Aston Triangle, Birmingham B4 7ET, UK.
Received: 19 November 2013 Accepted: 18 December 2014
Published: 23 December 2014
References
1. Aicardi J, Mumford J, Dumas C, Wood S: Vigabatrin as initial therapy for
infantile spasms: a european retrospective survey. Epilepsia 1996,
37:638–642.
2. Tolman JA, Faulkner MA: Vigabatrin: a comprehensive review of drug
properties including clinical updates following recent FDA approval.
Expert Opin Pharmacother 2009, 10:3077–3089.
3. Hardus P, Verduin W, Postma G, Stilma J, Berendschot T, Van Veelen C: Long
term changes in the visual fields of patients with temporal lobe epilepsy
using vigabatrin. Br J Ophthalmol 2000, 84:788–790.
4. Midelfart A, Midelfart E, Brodtkorb E: Visual field defects in patients taking
vigabatrin. Acta Ophthalmol Scand 2000, 78:580–584.
5. Gaily E, Jonsson H, Lappi M: Visual fields at school-age in children treated
with vigabatrin in infancy. Epilepsia 2009, 50(2):206–216.6. Wild JM, Chiron C, Ahn H, Baulac M, Bursztyn J, Gandolfo E, Goldberg I,
Goñi FJ, Mercier F, Nordmann JP, Safran AB, Schiefer U, Perucca E: Visual
field loss in patients with refractory partial epilepsy treated with
vigabatrin: final results from an open-label, observational, multicentre
study. CNS Drugs 2009, 23:965–982.
7. Schmidt T, Rüther K, Jokiel B, Pfeiffer S, Tiel-Wilck K, Schmitz B: Is visual field
constriction in epilepsy patients treated with vigabatrin reversible?
J Neurol 2002, 249:1066–1071.
8. Nousiainen I, Mäntyjärvi M, Kälviäinen R: No reversion in vigabatrin-associated
visual field defects. Neurology 2001, 57:1916–1917.
9. Manuchehri K, Goodman S, Siviter L, Nightingale S: A controlled study of
vigabatrin and visual abnormalities. Br J Ophthalmol 2000, 84:499–505.
10. Miller N, Johnson M, Paul S, Girkin CC, Perry JD, Endres M, Krauss GL: Visual
dysfunction in patients receiving vigabatrin: clinical and electrophysiologic
findings. Neurology 1999, 53:2082–2087.
11. Hardus P, Verduin W, Engelsman M, Edelbroek PM, Segers JP, Berendschot TT,
Stilma JS: Visual field loss associated with vigabatrin: quantification and
relation to dosage. Epilepsia 2001, 42:262–267.
12. Conway M, Cubbidge RP, Hosking SL: Visual field severity indices
demonstrate dose‐ dependent visual loss from vigabatrin therapy.
Epilepsia 2008, 49:108–116.
13. Maguire M, Hemming K, Wild JM, Hutton JL, Marson AG: Prevalence of
visual field loss following exposure to vigabatarin therapy: a systematic
review. Epilepsia 2010, 51(12):2423–2431.
14. Wild JM, Ahn HS, Baulac M, Bursztyn J, Chiron C, Gandolfo E, Safran AB,
Schiefer U, Perucca E: Vigabatrin and epilepsy: lessons learned. Epilepsia
2007, 48(7):1318–1327.
15. Wild JM, Flanagan JG, Barnes DA, Gilmartin BA, Good PA, Crews SJ: The
qualitative comparative analysis of the visual field using computer-
assisted, semi-automated and manual instrumentation. II. Statistical
analysis. Doc Ophthalmol 1984, 58:319–324.
16. Bengtsson B, Olsson J, Heijl A, Rootzén H: A new generation of algorithms
for computerized threshold perimetry, SITA. Acta Ophthalmol Scand 1997,
75:368–375.
17. Bengtsson B, Heijl A: SITA fast, a new rapid perimetric threshold test.
description of methods and evaluation in patients with manifest and
suspect glaucoma. Acta Ophthalmol Scand 1998, 76:431–437.
18. Heijl A, Lindgren G, Olsson J: Normal variability of static perimetric
threshold values across the central visual field. Arch Ophthalmol 1987,
105:1544–1549.
19. Wall M, Punke SG, Stickney TL, Brito CF, Withrow KR, Kardon RH: SITA
standard in optic neuropathies and hemianopias: a comparison with full
threshold testing. Invest Ophthalmol Vis Sci 2001, 42:528–537.
20. Wood JM, Wild JM, Hussey MK, Crews SJ: Serial examination of the normal
visual field using octopus automated projection perimetry evidence for
a learning effect. Acta Ophthalmol 1987, 65:326–333.
21. Bengtsson B, Heijl A: False-negative responses in glaucoma perimetry:
indicators of patient performance or test reliability? Invest Ophthalmol Vis
Sci 2000, 41(8):2201–2204.
22. Wild JM, Martinez C, Reinshagenn G, Harding GFA: Characteristics of a unique
visual field defect attributed to vigabatrin. Epilepsia 1999, 40:1784–1794.
23. Zhu H, Crabb DP, Fredette MJ, Anderson DR, Garway-Heath DF: Quantifying
discordance between structure and function measurements in the clinical
assessment of glaucoma. Arch Ophthalmol 2011, 129(9):1167–1174.
24. Russell RA, Garway-Heath DF, Crabb DP: New insights into measurement
variability in glaucomatous visual fields from computer modelling. PLoS
One 2013, 8(12):e83595.
25. Bengtsson B, Heijl A, Olsson J: Evaluation of a new threshold visual field
strategy, SITA, in normal subjects. Acta Ophthalmol Scand 1998, 76:165–169.
26. Wild JM, Pacey IE, Hancock SA, Cunliffe IA: Between-algorithm, between-
individual differences in normal perimetric sensitivity: Full threshold,
FASTPAC, and SITA. swedish interactive threshold algorithm. Invest
Ophthalmol Vis Sci 1999, 40:1152–1161.
27. Wild JM, Pacey IE, O’Neill EC, Cunliffe IA: The SITA perimetric threshold
algorithms in glaucoma. Invest Ophthalmol Vis Sci 1999, 40:1998–2009.
28. Ring HA, Reynolds EH: From Vigabatrin. In Recent Advances in Epilepsy.
Edited by Pedley T, Meldrum B. Edinburgh: Churchilll Livingstone;
1992:177–195.
29. Wild JM, Robson CR, Jones AL, Cunliffe IA, Smith PE: Detecting vigabatrin
toxicity by imaging of the retinal nerve fiber layer. Invest Ophthalmol Vis
Sci 2006, 47(3):917–924.
Conway et al. BMC Ophthalmology 2014, 14:166 Page 10 of 10
http://www.biomedcentral.com/1471-2415/14/16630. Lawthom C, Smith PE, Wild JM: Nasal retinal nerve fiber layer attenuation:
a biomarker for vigabatrin toxicity. Ophthalmology 2009, 116(3):565–571.
31. Bengtsson B, Heijl A: Comparing significance and magnitude of
glaucomatous visual field defects using the SITA and full threshold
strategies. Acta Ophthalmol Scand 1999, 77:143–146.
32. Bengtsson B, Heijl A: Evaluation of a new perimetric threshold strategy,
SITA, in patients with manifest and suspect glaucoma. Acta Ophthalmol
Scand 1998, 76:268–272.
33. Clayton LM, Stern WM, Newman WD, Sander JW, Acheson J, Sisodiya SM:
Evolution of visual field loss over ten years in individuals taking
vigabatrin. Epilepsy Res 2013, 105(3):262–271.
34. Hudson C, Wild JM, O’Neill EC: Fatigue effects during a single session of
automated static threshold perimetry. Invest Ophthalmol Vis Sci 1994,
35:268–280.
doi:10.1186/1471-2415-14-166
Cite this article as: Conway et al.: Does the Swedish Interactive Threshold
Algorithm (SITA) accurately map visual field loss attributed to vigabatrin?
BMC Ophthalmology 2014 14:166.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
